Krishnan B. Ramanathan

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.

Journal: Circulation

Published: August 30, 2025

Managing Acute Coronary Syndrome and Surgical Revascularization in a Patient With Severe Haemophilia A on Emicizumab: Lessons Learned From a Clinical Case.

Managing Acute Coronary Syndrome and Surgical Revascularization in a Patient With Severe Haemophilia A on Emicizumab: Lessons Learned From a Clinical Case.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: August 20, 2025

Recurrent STEMI After Surgical Aortic Valve Replacement.

Recurrent STEMI After Surgical Aortic Valve Replacement.

Journal: JACC. Case reports

Published: August 14, 2025

Safety and efficiency of implementation of high-sensitivity troponin T in the assessment of emergency department patients with cardiac chest pain.

Safety and efficiency of implementation of high-sensitivity troponin T in the assessment of emergency department patients with cardiac chest pain.

Journal: CJEM

Published: May 04, 2024

The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study.

The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study.

Journal: Open forum infectious diseases

Published: November 10, 2023

Increased Classical Monocytes in South Asian Compared With White Caucasian Individuals at Risk for Coronary Atherosclerosis.

Increased Classical Monocytes in South Asian Compared With White Caucasian Individuals at Risk for Coronary Atherosclerosis.

Journal: The Canadian journal of cardiology

Published: February 12, 2023

Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.

Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.

Journal: Neurology and therapy

Published: October 04, 2022

Genetic testing in monogenic early-onset atrial fibrillation.

Genetic testing in monogenic early-onset atrial fibrillation.

Journal: European journal of human genetics : EJHG

Published: August 27, 2022

Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.

Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 10, 2022

Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.

Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.

Journal: Frontiers in immunology

Published: January 11, 2022

Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis.

Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis.

Journal: CNS drugs

Published: December 21, 2021

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.

Journal: Nature biotechnology

Published: December 14, 2021

Showing 1-12 of 46

Last Updated: 09/26/2026